Skip to content

Effects of Tizanidine on sinus endoscopy bleeding

Investigation of preoperative oral Tizanidine on blood loss in endoscopic sinus surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016022625481N2
Enrollment
50
Registered
2016-10-29
Start date
2016-04-03
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Nasal polyposis. Condition 2: Nasal polyp. Polyp of nasal cavity

Interventions

Intervention 1: 1 intervention groups: ]n this group of patients recieve Placebo with 50 cc of water, one hour before surgery .During surgery patient's vital signs, including blood pressure measuremen
Treatment - Drugs
1 intervention groups: ]n this group of patients recieve Placebo with 50 cc of water, one hour before surgery .During surgery patient's vital signs, including blood pressure measurement, ECG, heart ra
2intervention groups: ]n this group of patients recieve 4mg Tizanidin with 50 cc of water, one hour before surgery .During surgery patient's vital signs, including blood pressure measurement, ECG, hea

Sponsors

Vice Chancellor for research of Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria: Age more than 16 years undergoing endoscopic sinus surgery • ASA class I and II Exclusion criteria : • high blood pressure (severe) • liver or kidney disease •coagulopathy • Diabetes • Abnormal blood sugar on the morning of the day of surgery • severe hypotension during surgery that requires intravenous administration of large volumes • Lack of consent to participate in the study have. Aspirin or any anticoagulants drugs. hemoglobin under 10.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Bleeding. Timepoint: after 1 hour. Method of measurement: check list.;Severity of nasal sinus bleeding. Timepoint: before induction, after induction, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80 minutes. Method of measurement: heart rate, systolic blood pressure, diastolic blood pressure, mean arterial pressure.

Secondary

MeasureTime frame
Surgeon consent. Timepoint: based on Likert scale. Method of measurement: It will be measured based on a verbal descriptive scale which is related with a visual bleeding score.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSaleheh Asghari

Mashhad University of Medical Sciences

fhayati@ut.ac.ir+98 915 516 4334

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026